These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9895043)

  • 41. Efficacy of cisapride therapy in functional dyspepsia.
    Kellow JE; Cowan H; Shuter B; Riley JW; Lunzer MR; Eckstein RP; Höschl R; Lam SK
    Aliment Pharmacol Ther; 1995 Apr; 9(2):153-60. PubMed ID: 7605855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of body position on postprandial perceptions, gastric emptying, and intragastric meal distribution: an ultrasonographic study in reclining healthy subjects.
    Valeur J; Berstad A; Hausken T
    Scand J Gastroenterol; 2015 Feb; 50(2):170-3. PubMed ID: 25515140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of metoclopramide oral tablets and solution in treatment of dysmotility-like dyspepsia.
    Banani SJ; Lankarani KB; Taghavi A; Bagheri MH; Sefidbakht S; Geramizadeh B
    Am J Health Syst Pharm; 2008 Jun; 65(11):1057-61. PubMed ID: 18499880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H(2) receptor antagonists and prokinetics in dyspepsia: a critical review.
    Bytzer P
    Gut; 2002 May; 50 Suppl 4(Suppl 4):iv58-62. PubMed ID: 11953351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cisapride improves nicotine-evoked antral hypomotility in smokers.
    Ohnishi H
    Kurume Med J; 1997; 44(4):253-62. PubMed ID: 9476468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three-dimensional ultrasonography of the gastric antrum in patients with functional dyspepsia.
    Gilja OH; Hausken T; Odegaard S; Berstad A
    Scand J Gastroenterol; 1996 Sep; 31(9):847-55. PubMed ID: 8888430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients.
    Wood SF; Penney SC; Cochran KM
    Scand J Gastroenterol Suppl; 1993; 195():5-10. PubMed ID: 8516659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia.
    al-Quorain A; Larbi EB; al-Shedoki F
    Scand J Gastroenterol; 1995 Jun; 30(6):531-4. PubMed ID: 7569759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses.
    Mearin F; Balboa A; Zárate N; Cucala M; Malagelada JR
    Am J Gastroenterol; 1999 Jan; 94(1):116-25. PubMed ID: 9934741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity.
    Farré R; Vanheel H; Vanuytsel T; Masaoka T; Törnblom H; Simrén M; Van Oudenhove L; Tack JF
    Gastroenterology; 2013 Sep; 145(3):566-73. PubMed ID: 23702005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neostigmine-induced postprandial phasic contractility in the proximal stomach and dyspepsia-like symptoms in healthy volunteers.
    Di Stefano M; Vos R; Klersy C; Lee KJ; Janssens J; Tack J
    Am J Gastroenterol; 2006 Dec; 101(12):2797-804. PubMed ID: 17227525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrointestinal hormone abnormalities and G and D cells in functional dyspepsia patients with gastric dysmotility.
    He MR; Song YG; Zhi FC
    World J Gastroenterol; 2005 Jan; 11(3):443-6. PubMed ID: 15637765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.
    Fraser RJ; Horowitz M; Maddox AF; Dent J
    Gut; 1994 Feb; 35(2):172-8. PubMed ID: 8307466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between gastrointestinal and extra-gastrointestinal symptoms and delayed gastric emptying in functional dyspeptic patients.
    Pallotta N; Pezzotti P; Calabrese E; Baccini F; Corazziari E
    World J Gastroenterol; 2005 Jul; 11(28):4375-81. PubMed ID: 16038037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.
    Jian R; Ducrot F; Ruskone A; Chaussade S; Rambaud JC; Modigliani R; Rain JD; Bernier JJ
    Dig Dis Sci; 1989 May; 34(5):657-64. PubMed ID: 2653742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cisapride provides symptomatic relief in functional dyspepsia associated with gastric myoelectrical abnormality.
    Chen JD; Ke MY; Lin XM; Wang Z; Zhang M
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1041-7. PubMed ID: 10930898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can dietary integrators provide a clinical benefit in the treatment of functional dyspepsia? results from a prospective study with TUBES Gastro.
    Molteni M
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):105-12. PubMed ID: 24780944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.
    Camilleri M; Malagelada JR; Abell TL; Brown ML; Hench V; Zinsmeister AR
    Gastroenterology; 1989 Mar; 96(3):704-12. PubMed ID: 2644150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
    Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.